JENNIFER RAWLS: Open Payments
NPI 1831770981 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 22 payments from 6 companies in 2025. Trend: 2023 $829 · 2024 $749 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $180 |
| Janssen Pharmaceuticals, Inc | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Corium, LLC | 1 | $8 |
Products named: VRAYLAR, INVEGA SUSTENNA, REXULTI, CAPLYTA, UZEDY, Azstarys.
Industry payments across AR — which companies pay providers there.
